
The CLEARTEST NT-pro BNP is a qualitative in-vitro rapid diagnostic test for the detection of the cardiac biomarker NT-pro BNP (N-terminal pro-B-type natriuretic peptide). The test serves as a supportive diagnostic tool in cases of suspected heart failure and for monitoring disease progression in therapeutic settings. It is designed for professional use in the point-of-care setting.
Application areas
Supportive diagnostics in cases of suspected heart failure
Differential diagnosis in cases of unclear shortness of breath (cardiac vs. pulmonary)
Monitoring of therapy progress in patients with known heart failure
Use in doctors' offices, clinics and emergency rooms
Use in high-risk patients, e.g., with hypertension, coronary artery disease, or advanced age.
Advantages at a glance
Qualitative rapid test for the detection of NT-proBNP
Test results within approximately 10 minutes
Lower detection limit: 0.45 ng/ml
Suitable for point-of-care use
Supports rapid diagnostic assessment in dyspnea
Simple and practical handling
Intended for professional use
Further information
NT-proBNP is produced in the heart muscle and released when the wall tension of the left ventricle is increased. This rapid test provides timely additional diagnostic information that should be evaluated within the clinical context and in combination with other examinations. The test does not replace further diagnostic procedures but can be a useful supplement to them.
Delivery information:
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel